Analystreport

Alder Biopharmaceuticals Inc (NASDAQ: ALDR) was upgraded by analysts at Morgan Stanley from an "underweight" rating to an "equal weight" rating.

ALDER BIOPHARMACEUTICALS INC  (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806